RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material， Registered As An Implanted Medical Device, API

As a manufacturer located in China, we are proud to introduce our innovative and life-changing product, RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material. Our product is not only registered as an implanted medical device, but also an active pharmaceutical ingredient (API), making it a versatile and valuable addition to the medical industry.

Bone injuries and fractures can be debilitating for patients, affecting their quality of life and causing them immense pain. Traditional bone repair methods involve the use of grafts or synthetic materials, which can have limited success rates and long recovery times. Our RhBMP-2 product is a breakthrough solution that addresses these issues and helps to promote faster and more effective bone regeneration.

At its core, our RhBMP-2 product is a recombinant human bone morphogenetic protein (rhBMP-2). This protein is a naturally occurring substance that plays a crucial role in bone development and regeneration. By isolating and producing this protein in a laboratory environment, we are able to create a potent and effective healing agent that can be used in a variety of bone repair procedures.

One of the key benefits of our RhBMP-2 product is its ability to stimulate bone growth and regeneration in a way that traditional methods simply cannot match. This protein works by activating specific cells within the body that are responsible for bone growth and repair, encouraging them to migrate to the injury site and begin the healing process. This results in faster and more effective bone regeneration and can help patients recover from their injuries in a shorter amount of time.

Another notable advantage of our RhBMP-2 product is its versatility. As both an implanted medical device and an API, it can be used in a range of medical applications, including spinal fusion surgery, orthopedic procedures, and dental implants. This versatility makes it an attractive option for medical professionals and could potentially lead to wider adoption and use of our product.

But perhaps the most compelling reason to consider our RhBMP-2 product is its proven track record of success. Clinical studies have shown that our product can significantly improve bone growth and repair rates, resulting in better patient outcomes and reduced recovery times. This is supported by the fact that our RhBMP-2 product has received regulatory approval in a number of countries, further validating its safety and efficacy.

In summary, our RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material is a revolutionary solution that has the potential to transform the way we approach bone repair and regeneration. Its potency, versatility, and proven effectiveness make it a valuable asset for medical professionals and an attractive option for patients who are seeking faster and more effective healing. We are committed to producing high-quality and innovative medical products, and we believe that our RhBMP-2 product is a testament to that commitment.

Structural Component: The product is using recombinant human bone morphogenetic protein-2 (rhBMP-2) as the active ingredient and using medical gelatin, soy lecithin and hydroxyapatite as the carrier materials. It is of sterile packaging.

Product Property: The product can induce directional differentiation of intracorporal mesenchymal stem cells into osteoblasts, after filled at the defect area of bone tissue, osteogenesis can be induced to stimulate the formation of bone and cartilage, so as to achieve tissue repair. It could be degraded and absorbed by the body.

Indications: The product is indicated for fill repair of bony defects, bone nonunion, bone delayed union, and graft repair of spinal fusion, joint fusion, and orthopedic bone graft.

Instructions for Use: The implantation dose of the product must be determined by orthopaedic surgeons with professional knowledge and the dosage should depend on the specific condition and size of trauma or defected area. The recommended dose for one single part is 4-6mg of rhBMP-2; the maximum dosage for one single use is 6mg of rhBMP-2. The product can be used alone or combined with other conventional therapy. If the defect is large, the product can be used in combination with autogenous/allogenous graft or other degradable grafting materials.

Contraindications:

1. The product is contraindicated for the patients with severe cardiac or renal insufficiency, liver function impairment and hematopoietic dysfunction.

2. The product should not be used in patients with the history of malignant tumors.

3. The product should be used with caution in patients needing  systemic application of glucocorticoids.

4. The product should be used with caution in patients with metabolic bone disease.

5. The product should be used with caution in pregnant women, nursing mothers and children.

[Name]

Chemical Name: Recombinant Human Bone Morphogenetic Protein-2

A new type bone repairing material which has biological activity.

[Indication]

Indicated in filling and repairing for various reasons caused bone defect, bone non-union, delayed bone healing or unhealing, as well as treated in spinal fusion, joint fusion and orthopedic bone graft repair.

R&D Strength

As the former gene engineering research center of Huadong Medicine Group, Jiuyuan is the earliest biopharmaceutical company realizing the industrialization of gene engineering in China and is known for its strong capability of sufficient experience in the R&D of genetic engineering drugs.

Based on the simultaneous development of innovative drugs and generic drugs, the company focuses on the development of recombinant proteins, antibodies, and combination products of biological and medical devices, and focuses on the development of new drugs in the fields of the tumor, hematology, orthopedics, diabetes (endocrine) and other fields. With the help of academician expert workstations, post-doctorate workstations, and other scientific research platforms, Jiuyuan devotes effort to develop the research and development of macromolecular drugs with the focus on insulin and monoclonal antibodies. In 2020, the company's R&D center and parts of production lines settled in Hangzhou Medicine Valley, and the level of R&D and production of software and hardware has been effectively improved.

Company Honor

National New High-tech Enterprise

Key New High-tech Enterprise of National Torch Plan

National superior enterprise of intellectual property

Provincial New High-tech Research & Development Center

Why choose us?

• We make it easy to purchase our Medical Device API products with hassle-free ordering.
• The company actively responds to the country's people-oriented development concept, and constantly absorbs high-quality talents to join.
• We are committed to providing Medical Device API products that meet the highest industry standards.
• Our company starts from the actual situation, gives full play to our talent and technology advantages, and continues to optimize our operation.
• As a supplier and manufacturer, we offer competitive pricing on Medical Device API products.
• We are committed to continuously exceeding customers' expectations and providing them with RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material， Registered As An Implanted Medical Device, API that meet rapidly changing manufacturing requirements and their business objectives.
• Our Medical Device API products are delivered on time and in perfect condition.
• We have a unique production process and strong technical strength, with perfect testing means and perfect quality assurance system to ensure the high quality of RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material， Registered As An Implanted Medical Device, API.
• Our Medical Device API products are packaged for convenience and ease of use.
• In order to adapt to the development needs of our company, to establish a good image of the company, to better meet the customers through the network to understand the company's products, to understand the company's services.

Hot Tags: rhbmp-2 (recombinant human bone morphogenetic protein-2) – a new bone repair material， registered as an implanted medical device, api, China rhbmp-2 (recombinant human bone morphogenetic protein-2) – a new bone repair material， registered as an implanted medical device, api manufacturers, suppliers, factory, Recombinant Human Bone Morphogenetic Protein-2, rhBMP-2 API, rhBMP 2 API, Recombinant Human Bone Morphogenetic Protein 2